Home   Categories   Grid

Subscribe Now

Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

27 May 2021

Dr Shankar Balasubramanian and Dr David Klenerman also discuss the possibility of $100 genome sequencing.


Unveiled: 30-year vision for Cambridge Biomedical Campus

Unveiled: 30-year vision for Cambridge Biomedical Campus

Unveiled: 30-year vision for Cambridge Biomedical Campus

21 May 2021

Homes, shops, restaurants and green space will be integrated alongside hospitals and world-leading life science work.


NeoGenomics to acquire liquid biopsy specialist Inivata in two-stage $415m acquisition

NeoGenomics to acquire liquid biopsy specialist Inivata in two-stage $415m acquisition

NeoGenomics to acquire liquid biopsy specialist Inivata in two-stage $415m acquisition

14 May 2021

It will accelerate the roll-out of products.


Meet the 12 Cambridge scientists made fellows of the Royal Society

Meet the 12 Cambridge scientists made fellows of the Royal Society

Meet the 12 Cambridge scientists made fellows of the Royal Society

14 May 2021

They were among 63 honoured.

1

Mogrify’s $17m second close will support immuno-oncology and ophthalmology programmes

Mogrify’s $17m second close will support immuno-oncology and ophthalmology programmes

Mogrify’s $17m second close will support immuno-oncology and ophthalmology programmes

04 May 2021

The Cambridge Science Park company’s Series A financing has totalled $33m.


‘New era for cancer therapeutics’ opens with acute myeloid leukaemia drug candidate, say Cambridge scientists

‘New era for cancer therapeutics’ opens with acute myeloid leukaemia drug candidate, say Cambridge scientists

‘New era for cancer therapeutics’ opens with acute myeloid leukaemia drug candidate, say Cambridge scientists

30 April 2021

STORM Therapeutics aims for clinical trials in 2022.


Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

23 April 2021

Its lead product can target bacteria in the lungs without damaging other cells.


Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

16 April 2021

It will receive $20m upfront.


Winners of Cambridge Independent Science and Technology Awards revealed

Winners of Cambridge Independent Science and Technology Awards revealed

Winners of Cambridge Independent Science and Technology Awards revealed

15 April 2021

Fourteen categories celebrated extraordinary talent, from biotech to AI.


Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

15 April 2021

The company has won Start-up of the Year at the Cambridge Independent Science and Technology Awards.


Stage is set for Cambridge Independent Science and Technology Awards

Stage is set for Cambridge Independent Science and Technology Awards

Stage is set for Cambridge Independent Science and Technology Awards

09 April 2021

A limited number of tickets are now on sale.


Eliem Therapeutics is out of stealth mode and $80m in the black

Eliem Therapeutics is out of stealth mode and $80m in the black

Eliem Therapeutics is out of stealth mode and $80m in the black

09 April 2021

Biotech’s targets include chronic pain, depression, epilepsy and anxiety


Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

08 April 2021

CEO Sarah Howell is nominated as CEO of the Year at the Cambridge Independent Science and Technology Awards.


Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

01 April 2021

He has been acting director since the death of Prof Michael Wakelam.


Precision medicine combination to be offered to more ovarian cancer patients

Precision medicine combination to be offered to more ovarian cancer patients

Precision medicine combination to be offered to more ovarian cancer patients

26 March 2021

Olaparib - discovered by Prof Steve Jackson’s team at the University of Cambridge - is available with bevacizumab under the Cancer Drugs Fund.

3

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

18 March 2021

The US government has struck a $231.8m deal for the delivery of 8.5 million tests.


Abcam reports revenue growth in spite of restrictions facing half the world’s labs

Abcam reports revenue growth in spite of restrictions facing half the world’s labs

Abcam reports revenue growth in spite of restrictions facing half the world’s labs

10 March 2021

The Cambridge-based life science research tools provider said demand has yet to return to normal.


Demand for lab space in Cambridge region at five-year high, says Bidwells

Demand for lab space in Cambridge region at five-year high, says Bidwells

Demand for lab space in Cambridge region at five-year high, says Bidwells

25 February 2021

Its report says take-up of office and lab space returned to trend levels in the second half of 2020.

1

Cambridge Festival launches programme of events

Cambridge Festival launches programme of events

Cambridge Festival launches programme of events

22 February 2021

The lineup for the inaugural online Cambridge Festival has gone live.


Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

17 February 2021

They will get seed funding, access to facilities and lab space.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More